Theravance Biopharma
TBPH
#6950
Rank
NZ$0.77 B
Marketcap
Country
$15.75
Share price
1.01%
Change (1 day)
3.84%
Change (1 year)

P/S ratio for Theravance Biopharma (TBPH)

P/S ratio as of April 2025 (TTM): 6.93

According to Theravance Biopharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.54. At the end of 2024 the company had a P/S ratio of 7.32.

P/S ratio history for Theravance Biopharma from 2014 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20247.32-24.85%
20239.75-33.78%
202214.7-0.02%
202114.7-7.45%
202015.9-20.88%
201920.1-14.81%
201823.6-75.93%
201798.1188.12%
201634.0130.35%
201514.8-64.07%
201441.1

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
1.50-78.42%๐Ÿ‡บ๐Ÿ‡ธ USA
14.4 107.30%๐Ÿ‡บ๐Ÿ‡ธ USA
5.91-14.76%๐Ÿ‡บ๐Ÿ‡ธ USA
2.61-62.41%๐Ÿ‡บ๐Ÿ‡ธ USA